#EliLilly is taking their weight loss drug money and partnering with #nvidia and #InsilicoMedicine to use an AI engine for designing new drugs.
I hope that humans are still required to sign off and be held accountable (as much as any multi-billion dollar corporation).
insilico.com/news/uiy12zc...
Hong Kong-listed #InsilicoMedicine has reached a deal with U.S. pharma giant #EliLilly for #AI-discovered #drugs. The two companies have worked together since 2023. Insilico’s CEO, #Zhavoronkov, said Eli Lilly has a #competitive edge in certain aspects of AI. www.cnbc.com/2026/03/29/e...
2) Bunların yarısı klinik aşamada. Şirket aralık ayında Hong Kong’ta halka arz oldu. Hisseleri şimdiye kadar yüzde 50 üzeri değerlendi. Her iki şirket, 2023 yılında yapay zekaya dayalı yazılım lisans anlaşmasını imzaladığından beri beraber çalışıyor. #elililly #insilicomedicine
#BraveNewWorld? At the #PMWC2026 panel on “AI-Driven #Biomarkers to Quantify #Aging” with #SteveHorvath #AltosLabs, #MahdiMoqri @harvard.edu, #HussainAhamed #Ultrahuman & chaired by @elonverse.bsky.social #InsilicoMedicine. Learning about a future with #wearables & “Dr. Agentic AI” #AgenticAI
A step forward for #InSilicoMedicine 🚀
Congrats to Maciej Malawski, our Director at Sano, joining the 2026 VPH Board of Directors.
Together we’re building the future of #DigitalHealthcare and #AIinMedicine. 💻🩺
#VPH #ComputationalModelling #SanoScience
Insilico CEO Alex Zhavoronkov explains how machines are accelerating drug discovery and shaping longevity science.
vist.ly/4skd9
#longevity #ArtificialIntelligence #DrugDiscovery #InsilicoMedicine #BiotechInnovation #AgingResearch #PrecisionMedicine #FutureOfHealth
Phase 1 dosing milestone for MEN2501 signals growing confidence in generative AI drug discovery and its healthspan implications.
vist.ly/4qmpn
#longevity #AIinBiotech #drugdiscovery #clinicalmilestone #healthspan #insilicomedicine
Insilico Medicine and Qilu Pharmaceutical team up to fast-track AI-designed drugs tackling heart, metabolism and aging-related diseases.
longevity.technology/news/120m-pa...
#AIinBiotech #Cardiometabolic #InsilicoMedicine #QiluPharma #PrecisionTherapy #longevity #HealthTech #DrugDiscovery
Fresh from its IPO at the end of last year, #InsilicoMedicine has added to its stable of partners after signing a new #alliance with #Servier that could be worth up to $888 million.
pharmaphorum.com/news/insilic...
The state of AI in Healthcare
tinyurl.com/25gdns9h
#AIinHealthcare #DeepMind #AlphaFold #AlphaEvolve #ProteinCode #personalized #preventive #predictive #nlm #genomic #InsilicoMedicine #histopathology
#technospirituality #rajesh30menon
#thursday #thursdayvibes #ThursdayThoughts #thursdaymorning
From research to real-world impact in healthcare.
#SanoCentreforComputationalMedicine #insilicomedicine #personalisehealthcare
Funding Raises: #XtalPi HK2.1B Post-IP Equity; #Zolve $51M Series B & $200M Debt; #CelestialAI $250M Series C1; #LilaSciences $200M Seed; #Terabase $130M Series C; #Cybereason $120M Series H; #Turing $111M Series E; #InsilicoMedicine $110M Series E; #Reflection $105M Series A
Insilico Medicine has unveiled "Supervisor," the first bipedal humanoid robot in its AI-driven, fully automated drug discovery lab. This robot helps scientists with tasks like pipetting, handling reagents, and supervising lab work.
#InsilicoMedicine #HumanoidRobots #AIDrugDiscovery
#UniversityofToronto and #InsilicoMedicine researchers developed an approach combining #QuantumComputing and #AI to design novel #cancer #drugs. They identified two molecules with #AntiCancer drug #potential. aibusiness.com/health-care/...
Thankfully as of 2025 various biotech companies are working on developing non-hormonal solutions fighting #endometriosis: #insilicomedicine and #fimmcyte being two of them. Read more on these developments here: endopaedia.com/blog.html (make sure to select your language in the top right corner)
Funding Raises: #Databricks $10B Series J & $5.25B Debt; #Innovaccer $654.1M Series F+; #InsilicoMedicine $601.3M Series C; #DataDirectNetworks $300M Private Equity; #HippocraticAI $276M Series B+; #Instabase $100M Series D;
#Highnote $90M Series B; #Render $80M Series C
